Valuation (47%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 29.00 | 18.12 |
| PEG Ratio (TTM) | 3.39 | 2.35 |
| P/S Ratio (TTM) | 1.66 | 3.97 |
| P/B Ratio (TTM) | 1.68 | 2.16 |
| P/FCF Ratio (TTM) | -17.94 | -1.92 |
| Price to 5YR AVG Earnings Ratio | 23.84 | 9.08 |
| Price to 5YR AVG FCF Ratio | 42.82 | -204.15 |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.92% | 1.13% |
| ROE (TTM) | 5.92% | 11.65% |
| Net Profit Margin (TTM) | 5.98% | 20.41% |
| ROIC 5YR AVG | 7.65% | 14.67% |
Growth (75%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 24.72% | 204.13% | 99.59% |
| Revenue | 22.65% | 37.62% | 20.86% |
| Net Income | 23.99% | 201.33% | 97.25% |
| Cash Flow | -342.58% | -191.14% | -153.17% |
Health (37%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.91 | 3.35 |
| Quick Ratio (TTM) | 0.91 | 3.29 |
| D/E Ratio (TTM) | 1.46 | 2.72 |
| Interest Coverage (TTM) | 1.22 | 1.67 |
| Piotroski F-Score | 4 | 4 |
| Altman Z-Score | 0.71 | 1.10 |
| LTL to 5YR AVG FCF | 39.91 | -293.82 |
| Shares Outstanding Growth 5YR AVG | -5.37% | 1.12% |